What is Doctolib?
Founded in 2013 and headquartered in Paris, France, Doctolib operates as a leading online health service platform. It facilitates seamless interaction between doctors and patients, streamlining appointment booking, telehealth services, and medical record management. Doctolib's innovative approach has positioned it as a key player in modernizing healthcare delivery, enhancing accessibility, and improving operational efficiency for medical professionals. The company's expansion into various European markets highlights its scalable business model and its commitment to transforming healthcare accessibility.
How much funding has Doctolib raised?
Doctolib has raised a total of $813.9M across 7 funding rounds:
Angel/Seed
$1.2M
Series A
$4.9M
Series B
$20M
Series C
$28M
Private Equity
$42M
Unspecified
$170M
Other Financing Round
$547.8M
Angel/Seed (2014): $1.2M, investors not publicly disclosed
Series A (2014): $4.9M, investors not publicly disclosed
Series B (2015): $20M supported by Accel Partners
Series C (2017): $28M featuring Accel and Bpifrance
Private Equity (2017): $42M backed by Eurazeo and Bpifrance
Unspecified (2019): $170M with participation from Bpifrance, Eurazeo, Kernel, Accel, and General Atlantic
Other Financing Round (2022): $547.8M led by General Atlantic, Bpifrance, and Eurazeo
Key Investors in Doctolib
General Atlantic
General Atlantic is a global growth equity firm that provides capital and strategic support to high-growth companies in sectors such as consumer, financial services, healthcare, life sciences, and technology. With dozens of portfolio companies worldwide and offices across the Americas, EMEA, and AsiaPacific, it partners with founders and management teams to accelerate growth, international expansion, and transformational initiatives.
Bpifrance
Founded in 2012, based out of France, Bpifrance finances companies - at each stage of their development - with credit, guarantees and equity. Bpifrance supports them in their innovation projects and internationally. Bpifrance also ensures their export activity through a wide range of products. Consulting, university, networking and an acceleration program for startups, SMEs and mid-cap companies are also part of the offer for entrepreneurs.
Eurazeo
Headquartered in Paris and founded in 1969, Eurazeo is a leading global investment company with considerable private equity, venture capital, real estate, and private debt, Eurazeo acsupports companies of all sizes in their development by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
What's next for Doctolib?
With substantial enterprise-level backing, Doctolib is poised for accelerated expansion and further innovation. The recent major strategic investment suggests a focus on scaling its operations, potentially entering new geographic markets, and enhancing its technological infrastructure. Future developments may include deeper integration of AI for diagnostic support, expanded telehealth capabilities, and further optimization of its platform for both healthcare providers and patients. Doctolib's continued growth trajectory indicates a strong potential for further market penetration and leadership in the digital health landscape.
See full Doctolib company page
